CRISPR Therapeutics AG 10-K for FY2022
CRISPR Therapeutics AG (CRSP)
10-K
2023-02-21
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 21, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.2M
- down 99.9% from $914.96M a year earlier
- Net loss
- $650.18M
- compared with net income of $377.66M a year earlier
- Diluted EPS
- -$8.36
- compared with $4.70 a year earlier